I, Qi Tongwei, started with black technology and broke through the deadlock and was reborn

Gao Xiaoqin listened and responded with a smile:

"As the saying goes, if you want to do your work well, you must first sharpen your tools. Without good equipment, how can you develop good products?"

After hearing this, everyone nodded.

Let’s not talk about how effective Xuekang No. 1 is.

Just by looking at the investment in equipment, they can tell that Shanshui Pharmaceutical is a company that focuses on research and development.

Many domestic pharmaceutical companies boast about their focus on R&D and innovation.

In fact, it is nothing. They are not willing to invest money in buying equipment for research and development.

From this perspective, at least this is Shanshui Pharmaceutical's attitude.

Soon, the main event began.

This is an introduction to the product Xuekang No. 1.

Including R&D principles, pharmacological mechanisms, etc.

Gao Xiaoqin couldn't do this kind of professional work, so she had to hand it over to the director of the R&D department.

In the laboratory's conference room.

An introduction meeting for the targeted drug Xuekang No. 1 was proceeding intensely.

The top-secret information about this medicine was also distributed to everyone.

Here is the most detailed explanation of this medicine.

Not only are these people coming to the hospital experts, they also have rich clinical experience.

Whether he is the real Li Kui or the real fake Li Kui, they can't hide it from their eyes at all.

After they read the information, they immediately realized that this Xuekang No. 1 product was suitable for them.

Its mechanism of action is different from any targeted drug currently on the market.

He utilized the principle of autophagy and enhanced autophagy through a special protease.

It is equivalent to arming immune cells from ordinary soldiers into special forces.

And it is equipped with a friend-or-foe identification device.

Allowing them to accurately identify tumor cells and then quickly kill them with the weapons in their hands.

This means that the side effects of this drug are minimal.

After watching it, several experts couldn't help but discuss it.

Vice President Du Qiang couldn't help but speak first:

"Oh my God, this is incredible. Whoever discovered this protease must be a genius."

Since we are all insiders, we can tell at a glance that this enzyme is the key.

Ren Kanghua, director of the Hematology Department, continued:

"Yes, from a theoretical perspective alone, it's at least one generation ahead of existing targeted drugs."

Others also echoed:

"Under this principle, the harm to the human body is minimal."

"It's really eye-opening. This is really good news for leukemia patients."

Du Qiang looked at Gao Xiaoqin and asked:

"You must have invested a lot of experimental costs in discovering this enzyme, right?"

Hearing this, Gao Xiaoqin smiled implicitly.

In fact, there is no R&D cost at all. These are all ready-made principles provided by Qi Tongwei.

They just copied the homework.

Of course, this must not be said out loud.

At this time, Ren Kanghua raised a question and said:

"But theories are just theories. What are the ultimate effects on the human body? Do you have any data?"

Because for a drug, especially a targeted drug.

Theoretical effects and actual effects are often two different things.

Ultimately, it all depends on how effective it is after people eat it.

Other experts also agreed with the questions raised by Ren Kanghua.

Vice President Du Qiang asked:

"Mr. Gao, what are your clinical trial data like?"

Gao Xiaoqin was well prepared for this question.

The clinical trial data was immediately shown to everyone.

"Dear experts, based on the results of clinical trials, our ultimate efficacy rate can reach over 95%."

"Of course... in addition to data, we also have more intuitive ways of displaying it."

The 95% efficiency alone was enough to shock them.

Gao Xiaoqin's words aroused everyone's interest.

"More intuitive?"

Ren Kanghua's face was full of doubts.

Gao Xiaoqin nodded and said, "Experts, please follow me."

Then, he took everyone to another laboratory.

Then he said to the researchers in the laboratory:

"let's start."

So the researchers immediately started working on it.

Gao Xiaoqin introduced Du Qiang and his group:

“This is our most advanced smart lab.”

"Here, we can truly simulate the process of drug action in the body."

"Everyone can look at this big screen."

Everyone was surprised to see the researchers connecting special equipment to the experimental mice.

Then Xuekang No. 1 was injected into the mice.

Then images began to appear on the big screen.

It fully demonstrates the process from the drug entering the body to enhancing autophagic cells.

Then accurately find the tumor cells and eliminate them.

The whole process is clearly displayed through the picture.

It shocked everyone present.

Soon, the experiment ended.

When the equipment was removed from the mouse, the mouse, which had originally suffered from leukemia, was now alive and well.

“Shocking… so shocking.”

Du Qiang couldn't help but sigh, and then asked:

"Why have I never seen this equipment before?"

Gao Xiaoqin responded: "We made this ourselves."

“Of course not anywhere else.”

"Unfortunately, research has shown that some patients may resist this enzyme."

"So our efficiency can only be 95 percent."

Hear this.

Ren Kanghua said with a little excitement:

"It's already amazing. To be able to achieve a 95% effectiveness rate with minimal side effects is unimaginable."

After coming out of the laboratory, everyone went to the conference room.

Gao Xiaoqin could tell from their performance that they must be very satisfied with her Xuekang No. 1.

This also made her feel more at ease.

Next, it’s time to talk about cooperation.

In the conference room.

Gao Xiaoqin and Zhong Xiaokai are both here.

Several experts from the hospital sat down and were still discussing enthusiastically.

Then Du Qiang asked:

"Boss, your drug is priced so low, it must be selling well, right? But why don't you have any real case data samples?"

Since it involves market issues, it is naturally Zhong Xiaokai's turn to answer.

He responded:

"That's what happened, Dean Du. You might not know this."

"Currently, most hospital channels are monopolized by foreign targeted drug agents."

"We haven't been able to collaborate with the hospital yet."

Hearing this, Du Qiang couldn't help but frown.

He said with an unhappy look: "The current market is full of capital monopoly."

"It would be unjust if such a good medicine were to be buried."

Zhong Xiaokai quickly replied:

"Dean Du, you are absolutely right."

"That's why we found you, hoping to cooperate with you."

"I have an experimental project here. We plan to provide free drug treatment to 500 leukemia patients."

"I hope this project can dispel patients' concerns about us."

"We have all the volunteers, but we haven't finalized the hospital arrangements yet."